With a focus on advancing and commercializing therapies to improve cancer treatment outcomes, we strive to provide new compounds to increase the efficacy and safety of cancer radiation sensitizers and normal tissue radiation protectant drugs. We are currently developing novel drugs that offer the potential to improve efficacy , improve tolerability and increase the safety of radiation therapy for oncology patients.